Mollie E. Plekan

机构：Alnylam Pharmaceuticals (United States)

发表论文 5 篇 · 总被引 63 次 · h-index 2

代表论文

• Rare loss of function variants in the hepatokine gene INHBE protect from abdominal obesity (2022 · Nature Communications · 被引 59)
• Rare predicted loss-of-function and damaging missense variants in CFHR5 associate with protection from age-related macular degeneration (2025 · The American Journal of Human Genetics · 被引 3)
• Rare predicted loss-of-function and damaging missense variants in CFHR5 associate with protection from age-related macular degeneration (2024 · medRxiv · 被引 1)
• Abstract 4140003: Impact of Long-Term Blood Pressure Variability on Adverse Cardiovascular Outcomes in High- and Low-Risk Populations (2024 · Circulation)
• Transcript-aware analysis of rare predicted loss-of-function variants in the UK Biobank elucidate new isoform-trait associations (2023)